See article by Riksen et al. [8] (pages 271-276) in this reaction equilibrium will shift toward AdoHcy production issue.
and simultaneously tend to lower the free Ado concenBased on epidemiological studies, homocysteine (Hcy) tration. Riksen and colleagues argue that because Ado has is regarded as an independent risk indicator for occlusive several well known, protective actions in the cardiovascuvascular diseases [1, 2] . Under experimental conditions, lar system mediated by purine surface receptors [9, 10] , the increased Hcy concentrations have been found to result in increased removal of Ado, due to increased Hcy conendothelial dysfunction, leukocyte adhesion, and smooth centrations, would significantly lower the Ado concenmuscle and collagen proliferation [3] [4] [5] [6] . However, the tration at these receptors and by diminishing the protective underlying molecular and metabolic links have not been actions potentially permit deleterious effects on the carconclusively elucidated [7] . Thus, it still remains to be diovascular system. determined whether Hcy indeed represents a risk factor or The hypothesis by Riksen et al. [8] is not the first rather a risk indicator.
proposal that attempts to provide a rationale for underIn this issue of the Journal, Riksen et al.
[8] present a standing the unfortunate effects that are often found to be new hypothesis on the relationship of Hcy and some of its associated with enhanced Hcy plasma levels. Previous presumed effects. This hypothesis is centered on the hypotheses that have been considered include (for a metabolism of Hcy with the purine adenosine (Ado) (Fig. metabolic scheme see Fig. 1 . The reaction which takes place at lysine residues of proteins may Under normal physiological conditions, the net flux significantly decrease enzyme activities, as shown for through this pathway is toward Hcy and Ado production methionyl-tRNA synthetase, trypsin, and lysine oxidase because both compounds are rapidly metabolized, thus,
[11]. Hcy thiolactone may be converted to Hcy by the their concentrations are kept low. In addition, AdoHcy is action of thiolactonase / paraoxonase, which is associcontinuously produced from S-adenosylmethionine ated with the high-density lipoprotein (HDL) fraction of (AdoMet) via the transmethylation pathway: serum lipoproteins. Recently, this enzyme activity was suggested to contribute to the protective role of the
HDL fraction against oxidative damage and Hcy toxicia reaction that is nonreversible under physiological conty [12] . ditions. However, the AdoHcy hydrolase-catalysed re-2. Free Hcy has a thiol group that may interact with the action depends on the concentration of each of the thiol groups of proteins, forming disulfide bonds. Aside reactants AdoHcy, Hcy, and Ado (reaction (1) The uncertainty surrounding whether and, if so, to which proliferation and reduce nitric oxide availability extent Hcy is involved in the pathogenesis of vessel [17, 18] . diseases is largely complicated by the following two facts: 4. Sulfane sulfur compounds contain a labile, highly
(1) Hcy exists in various fractions that may have different reactive sulfur atom at a reduced oxidation state cobiological effectiveness, and (2) Hcy may occur in a wide valently bound to another sulfur atom. This unstable concentration range under pathophysiological conditions. and reactive compound is formed through enzymatic Re: (1) The largest fraction of Hcy in human plasma is metabolism of Hcy, homocystine, or its mixed disulfide bound to plasma proteins through disulfide bonds with with cysteine. Sulfane sulfur has effects that are conprotein cysteines (¯80%). In the protein-unbound fraction, sistent with a role in atherogenesis [19] .
Hcy exists either as free reduced Hcy (physiologically 5. Nitric oxide (NO) bioavailability may be significantly minor subfraction, 1-2%) or as homocystine or mixed limited when Hcy concentrations are enhanced. Aside disulfides. The respective fractions may differ under from favoring increased levels of oxygen radicals, conditions of elevated total Hcy concentrations. The sum which may interfere with NO production (see above), of the above fractions is referred to as total plasma an enhanced concentration of asymmetrical dimethylarhomocysteine (plasma tHcy) and does not include Hcy ginine (ADMA), an endogenous inhibitor of nitric oxide thiolactone [21] . synthase, has been shown in the presence of elevated Re: (2) Depending on the (patho)physiological conHcy [5] . This effect might aggravate the effects of dition, the Hcy plasma concentration may vary over a wide oxLDL, which increases endothelial cell ADMA prorange. While the physiological concentration of total Hcy duction.
is around 10 mmol / l [21] , mild Hcy elevations (.15 6. Transmethylation reactions may be decreased following mmol / l) occur in about 1 / 3 of patients with arterial vessel an increase of the Hcy concentration. This notion is disease [7, 22] . Also, a declining renal function may result based on the fact that increased concentrations of Hcy in mild to moderate elevations of plasma Hcy. Untreated lead to tissue accumulation of AdoHcy [6, 20] and that vitamin deficiencies, e.g., B-12 or folate deficiency, may AdoHcy is a potent feedback inhibitor of transmethylagive rise to moderate (.30 mmol / l) or even severe (.100 tion. A reduced methylation rate could result in various mmol / l) increases of plasma Hcy. Finally, inborn errors of unfortunate effects (e.g., impeded DNA and protein Hcy metabolism can result in plasma concentrations of up methylation). This concept suggests that the increased to 400 mmol / l [7, 21] . are sufficient to explain the observed effects.
